Location History:
- Yarmouth, MA (US) (2022)
- Yarmouth, ME (US) (2021 - 2023)
Company Filing History:
4 out of 50 
1 out of 2,009 
Years Active: 2021-2023
Title: Penrose O'Donnell: Innovator in CRISPR Technology
Introduction
Penrose O'Donnell is a notable inventor based in Yarmouth, Maine, who has made significant contributions to the field of genetic engineering. With a total of four patents to his name, O'Donnell's work primarily focuses on CRISPR technology and its applications in treating various medical conditions.
Latest Patents
O'Donnell's latest patents include groundbreaking methods and compositions related to CRISPR/Cas systems. One of his patents describes CRISPR/Cas-related methods for treating herpes simplex virus, detailing systems and methods for editing RS1, RL2, and/or LAT genes in human cells. Another significant patent addresses alpha 1-antitrypsin (A1AT) deficiency, presenting CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions.
Career Highlights
Throughout his career, O'Donnell has worked with prominent organizations such as Editas Medicine, Inc. and Duke University. His innovative research has positioned him as a key figure in the advancement of CRISPR technology, contributing to the development of therapies that have the potential to transform medical treatments.
Collaborations
O'Donnell has collaborated with esteemed colleagues, including Ari E. Friedland and David A. Bumcrot, further enhancing the impact of his work in the scientific community.
Conclusion
Penrose O'Donnell's contributions to CRISPR technology and genetic engineering highlight his role as a leading inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.